SUBSCRIBE
SUBSCRIBE
News   Drug Development

NC’s PPD, Inc. Clinical Trial Shows New Statin is Safe

July 31, 2007 | 
1 min read

WILMINGTON, NC--PPD Inc. (NASDAQ:PPDI) says it has completed a first-in-human study with its new statin for the treatment of high cholesterol. The compound was safe and well tolerated at all doses in this clinical trial.

Clinical research Phase I
PPD
MORE ON THIS TOPIC
broken human head conceptual digital illustration
Huntington’s disease
Sage Scraps Huntington’s Hopeful After Disappointing Phase II Data
November 20, 2024
 · 
2 min read
 · 
Tristan Manalac
Human liver protection. Wireframe low poly style. Concept for medical, pharmacology, treatment of the hepatitis. Abstract modern 3d vector illustration on dark blue background.
MASH
Novo, Viking Heat Up MASH Space with Promising Data at AASLD24
November 20, 2024
 · 
3 min read
 · 
Tristan Manalac
Podcast
RFK Jr.’s HHS Nomination, Biogen’s Lupus Win and Leqembi Struggles, Neurogene’s Rough Month, More
November 20, 2024
 · 
1 min read
 · 
Heather McKenzie
Pictured: Biogen's signage at its headquarters in Massachusetts
Immunology and inflammation
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eyes Second Phase III
November 19, 2024
 · 
3 min read
 · 
Tristan Manalac